Breaking News Instant updates and real-time market news.

DPZ

Domino's Pizza

$246.55

-23.42 (-8.68%)

07:06
07/17/19
07/17
07:06
07/17/19
07:06

Domino's Pizza recent selloff in shares overdone, says JPMorgan

JPMorgan analyst John Ivankoe views the 13% pullback in shares of Domino's Pizza over the past two days as overdone. He believes the stock should be bought at current levels. The analyst lowered his price target for Domino's to $270 from $290 following the company's Q2 results and keeps an Overweight rating on the name. Ivankoe sees sustainable same-store-sales growth at least in line with peers at 2%-3%, noting this is at the lower end of the company's guided 3%-6% range. Domino's deserves to trade at a multiple on top of its peers, Ivankoe tells investors in a research note.

  • 13

    Nov

DPZ Domino's Pizza
$246.55

-23.42 (-8.68%)

07/11/19
MSCO
07/11/19
NO CHANGE
Target $305
MSCO
Overweight
Domino's reasonably insulated from 3rd party delivery risk, says Morgan Stanley
Morgan Stanley analyst John Glass said he is not dismissive of the sales risk posed to Domino's Pizza (DPZ) by third-party food delivery aggregators, but his county-by-county analysis of its U.S. stores overlapped against markets where third party delivery is or is expected to be most concentrated leads him to believe that the risk has a "reasonable boundary" of a 1%-2% impact on same-store sales. Using the same data, he concluded that Domino's still has an opportunity to grow its current U.S. store base of about 5,900 to at least 8,000-9,000 units over time, said Glass, who keeps an Overweight rating on Domino's shares with a $305 price target. Publicly traded companies that operate third-party food delivery services include GrubHub (GRUB) and Uber (UBER).
07/12/19
MAXM
07/12/19
NO CHANGE
Target $315
MAXM
Buy
Domino's Pizza EPS growth to accelerate in 2020, says Maxim
Maxim analyst Stephen Anderson kept his Buy rating and $315 price target on Domino's Pizza (DPZ) ahead of its Q2 results next week. The analyst expects the management to address its "fortressing" strategy that will allow the company to pick up market share given the ongoing troubles at Papa John's (PZZA). Anderson lowers his FY19 EPS outlook to $9.74 from $9.82 but believes that Domino's Pizza valuation is "attractive" at 10% below the August 2018 high. In FY20, the analyst expects the company's earnings to accelerate to $11.71.
07/16/19
SPHN
07/16/19
NO CHANGE
Target $325
SPHN
Overweight
Domino's domestic comp deceleration to be focal point, says Stephens
In a "first look" note ahead of Domino's Pizza's earnings conference call, Stephens analyst Will Slabaugh said he expects a focal point of the call to be the company's report of domestic same-store sales growth that decelerated 240 basis points on a 2-year basis in Q2. While he continues to view Domino's shares as warranting a premium valuation compared to franchised peers, Slabaugh said he expects investors to want more evidence of growth stabilization before re-rating the stock significantly higher. He keeps an Overweight rating on Domino's.
07/17/19
MZHO
07/17/19
NO CHANGE
Target $305
MZHO
Buy
Domino's Pizza price target lowered to $305 from $320 at Mizuho
Mizuho analyst Jeremy Scott lowered his price target for Domino's Pizza to $305 from $320 while maintaining a Buy rating on the shares following the company's Q2 results. Most of the earnings beat came on the tax line as global retail sales growth of ~1% below expectations, driven primarily by soft traffic in the U.S., Scott tells investors in a research note. He believes, however, that while Domino's "continues to battle against an aggressive" third-party delivery industry, its investments in digital and aggressive unit expansion in the U.S. will position it well when the "delivery dust settles."

TODAY'S FREE FLY STORIES

LNDC

Landec

$9.41

0.14 (1.51%)

07:11
10/21/19
10/21
07:11
10/21/19
07:11
Conference/Events
Landec management to meet with Maxim »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 28

    Oct

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

LAC

Lithium Americas

$3.02

0.04 (1.34%)

07:09
10/21/19
10/21
07:09
10/21/19
07:09
Hot Stocks
Lithium Americas appoints Yuan Gao to board of directors »

Lithium Americas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARQL

ArQule

$9.13

-0.17 (-1.83%)

07:08
10/21/19
10/21
07:08
10/21/19
07:08
Hot Stocks
ArQule announces preclinical data showing potential for miransertib to treat VMs »

ArQule announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 30

    Oct

SON

Sonoco

$58.07

0.85 (1.49%)

07:08
10/21/19
10/21
07:08
10/21/19
07:08
Upgrade
Sonoco rating change  »

Sonoco upgraded to Market…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$130.91

-1.46 (-1.10%)

07:08
10/21/19
10/21
07:08
10/21/19
07:08
Conference/Events
Disney management to meet with Oppenheimer »

Luncheon Meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 07

    Nov

IDRA

Idera Pharmaceuticals

$2.68

-0.01 (-0.37%)

07:07
10/21/19
10/21
07:07
10/21/19
07:07
Hot Stocks
Idera Pharmaceuticals annnounces U.S. patent for tilsotolimod »

Idera Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBI

Brickell Biotech

$4.10

-0.08 (-1.91%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Conference/Events
Brickell Biotech management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

SEAS

SeaWorld

$27.88

0.23 (0.83%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Hot Stocks
SeaWorld to open second Sesame Place theme park in San Diego in 2021 »

SeaWorld and Sesame…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARMP

Armata Pharmaceuticals

$4.10

0.05 (1.23%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Hot Stocks
Armata Pharmaceuticals announces receipt of $1.3M R&D Tax Incentive »

Armata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGTC

Applied Genetic

$3.05

-0.06 (-1.93%)

07:06
10/21/19
10/21
07:06
10/21/19
07:06
Hot Stocks
Applied Genetic presents data from non-clinical studies evaluating AAV vectors »

Applied Genetic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$236.29

0.99 (0.42%)

07:05
10/21/19
10/21
07:05
10/21/19
07:05
Recommendations
Apple analyst commentary  »

iPhone Pro lead times…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

AXLA

Axcella

$5.10

0.14 (2.82%)

07:05
10/21/19
10/21
07:05
10/21/19
07:05
Conference/Events
Axcella management to meet with SVB Leerink »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 08

    Nov

07:05
10/21/19
10/21
07:05
10/21/19
07:05
General news
European stock markets are broadly higher »

European stock markets…

07:05
10/21/19
10/21
07:05
10/21/19
07:05
General news
FX Update: Sterling has outperformed »

FX Update: Sterling has…

AZN

AstraZeneca

$43.86

-0.25 (-0.57%)

07:04
10/21/19
10/21
07:04
10/21/19
07:04
Hot Stocks
AstraZeneca announces FDA approval of Farxiga »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 06

    Nov

  • 18

    Nov

  • 07

    Dec

AXSM

Axsome Therapeutics

$21.08

-1.46 (-6.48%)

07:04
10/21/19
10/21
07:04
10/21/19
07:04
Hot Stocks
Axsome Therapeutics completes patient enrollment in CONCERT Phase 2 trial »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGX

Argan

$39.36

0.82 (2.13%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Conference/Events
Argan management to meet with Lake Street »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

ALKS

Alkermes

$18.17

0.45 (2.54%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Hot Stocks
Alkermes partners with Fred Hutchinson Cancer center to evalute ALKS 4230 »

Alkermes has entered into…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

AYTU

Aytu BioScience

$1.20

-0.04 (-3.23%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Hot Stocks
Aytu BioScience reports addition of Tuzistra XR to national PBM formulary »

Aytu BioScience announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$58.91

-1.35 (-2.24%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Hot Stocks
Teradyne to acquire AutoGuide Mobile Robots for $165M »

Teradyne and AutoGuide…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

BIOL

Biolase

$0.80

-0.199 (-19.90%)

07:03
10/21/19
10/21
07:03
10/21/19
07:03
Earnings
Biolase sees Q3 net loss ($5.4M)-($5.8M) »

Q3 EPS consensus (13c).…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

RESN

Resonant

$2.32

-0.12 (-4.92%)

07:01
10/21/19
10/21
07:01
10/21/19
07:01
Hot Stocks
Resonant says customers shipped more than 1.5M units in Q3 »

Resonant announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

GCI

Gannett

$10.91

-0.01 (-0.09%)

, NEWM

New Media

$8.89

0.08 (0.91%)

06:59
10/21/19
10/21
06:59
10/21/19
06:59
Periodicals
Gannett, New Media deal could be in jeopardy due to regulatory glitch, NYP says »

The proposed acquisition…

GCI

Gannett

$10.91

-0.01 (-0.09%)

NEWM

New Media

$8.89

0.08 (0.91%)

APO

Apollo Global

$39.96

-0.06 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 31

    Oct

  • 04

    Nov

  • 07

    Nov

  • 14

    Nov

  • 14

    Nov

LNG

Cheniere Energy

$62.51

0.05 (0.08%)

06:58
10/21/19
10/21
06:58
10/21/19
06:58
Initiation
Cheniere Energy initiated  »

Cheniere Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

AUB

Atlantic Union Bankshares

$37.68

0.37 (0.99%)

06:57
10/21/19
10/21
06:57
10/21/19
06:57
Downgrade
Atlantic Union Bankshares rating change  »

Atlantic Union Bankshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

  • 13

    Nov

  • 10

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.